forth below.
Elan Patent Rights
shall also include all continuations, continuations-in-part, divisionals and
re-issues of such patents and patent applications and any patents issuing
thereon and extensions of any patents licensed hereunder.
Elan Patent Rights
shall further include any patents or patent applications covering any improved
methods of making or using the Product invented or acquired by Elan (and/or its
Affiliates) during the term of the Elan/Acorda Agreement and under which Elan
(and/or its Affiliates) has a right to grant a licence under the Elan/Acorda
Agreement, and Elan's (and/or its Affiliates) interest in any intellectual
property conceived reduced to practice or otherwise developed in connection with
the Project (as defined in the Elan/Acorda Agreement).
1806
Formulations and their use in the treatment of
neurological diseases
Pending:
Canada
Ireland
Japan
2054822
3952/90
349324/1991
Issued:
Australia
Europe
New Zealand
South Africa
United States
657706
484186
240439
91/8711
5370879
5540938
5580580
24
EXHIBIT 1.31
SIDE AGREEMENT
(Filed as Exhibit 10.11 to the Registrant's Registration Statement on Form S-1,
No. 333-128827, filed on October 5, 2005)
25